tiprankstipranks
AbbVie (GB:0QCV)
LSE:0QCV
UK Market

AbbVie (0QCV) Technical Analysis

Compare
9 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
AbbVie’s (0QCV) Moving Averages Convergence Divergence (MACD) indicator is 5.92, suggesting AbbVie is a Sell.
AbbVie’s (0QCV) 20-Day exponential moving average is 190.93, while AbbVie’s (0QCV) share price is $203.59, making it a Buy.
AbbVie’s (0QCV) 50-Day exponential moving average is 184.56, while AbbVie’s (0QCV) share price is $203.59, making it a Buy.

AbbVie (0QCV) Pivot Points

Feb 23, 2025, 04:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
194.13
195.31
197.69
198.87
201.25
202.43
204.81
Fibonacci
195.31
196.67
197.51
198.87
200.23
201.07
202.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (0QCV) Moving Averages

Feb 23, 2025, 04:55 PM
Period
Simple
Exponential
MA5
198.20Buy
199.06Buy
MA10
195.22Buy
195.87Buy
MA20
189.94Buy
190.93Buy
MA50
180.35Buy
184.56Buy
MA100
182.21Buy
182.24Buy
MA200
178.78Buy
177.69Buy
AbbVie’s (0QCV) 10-Day exponential moving average is 195.87, while AbbVie’s (0QCV) share price is $203.59, making it a Buy.
AbbVie’s (0QCV) 100-Day exponential moving average is 182.24, while AbbVie’s (0QCV) share price is $203.59, making it a Buy.
AbbVie’s (0QCV) stock price is $203.59 and AbbVie’s (0QCV) 50-day simple moving average is 180.35, creating a Buy signal.
AbbVie’s (0QCV) stock price is $203.59 and AbbVie’s (0QCV) 100-day simple moving average is 182.21, creating a Buy signal.
AbbVie’s (0QCV) stock price is $203.59 and AbbVie’s (0QCV) 200-day simple moving average is 178.78, creating a Buy signal.

AbbVie (0QCV) Technical Indicators

Feb 23, 2025, 04:55 PM
Name
Value
Implied Action
RSI (14)
80.60
Sell
STOCH (9,6)
97.60
Sell
STOCHRSI (14)
98.85
Sell
MACD (12,26)
5.92
Sell
ADX (14)
29.73
Neutral
Williams %R
0.00
Sell
CCI (14)
137.31
Sell
ATR (14)
3.84
-
Ultimate Oscillator
78.43
Buy
ROC
7.03
Buy
AbbVie’s (0QCV) Relative Strength Index (RSI) is 80.60, creating a Sell signal.
AbbVie’s (0QCV) Trend Strength Indicator (ADX) is 29.73, creating a Neutral signal.
AbbVie’s (0QCV) Commodity Channel Index (CCI) is 137.31, creating a Sell signal.
AbbVie’s (0QCV) Price Rate of Change (ROC) is 7.03, creating a Buy signal.

FAQ

Is 0QCV a Buy, Hold, or Sell?
Based on 0QCV’s technical indicators, 0QCV is a Buy.
    What is 0QCV’s RSI (14)?
    0QCV’s RSI (14) is 80.60, which suggests 0QCV is a Sell.
      What is 0QCV’s MACD?
      0QCV’s MACD is 5.92, which suggests 0QCV is a Sell.
        What is 0QCV’s 5-day moving average?
        0QCV’s 5-day moving average is 198.20, which suggests 0QCV is a Buy.
          What is 0QCV’s 20-day moving average?
          0QCV 20-day moving average is 189.94, which suggests 0QCV is a Buy.
            What is 0QCV’s 50-day moving average?
            0QCV’s 50-day moving average is 180.35, which suggests 0QCV is a Buy.
              What is 0QCV’s 200-day moving average?
              0QCV’s 200-day moving average is 178.78, which suggests 0QCV is a Buy.
                What is 0QCV’s Williams % R (14)?
                0QCV’s Williams % R (14) is 0.00, which suggests 0QCV is a Sell.
                  What is 0QCV’s CCI (14)?
                  0QCV’s CCI (14) is 137.31, which suggests 0QCV is a Sell.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis